Company Filing History:
1 out of 20 
1 out of 6 Years Active: 2019
Title: Seong In Lim: Innovator in Vaccine Development
Introduction
Seong In Lim is a notable inventor based in Anyang-si, South Korea. He has made significant contributions to the field of vaccine development, particularly in the area of classical swine fever. His innovative approach combines plant biotechnology with vaccine production, showcasing the potential of using plants as bioreactors.
Latest Patents
Seong In Lim holds a patent for a vaccine composition for classical swine fever derived from plants. The patent describes a recombinant vector designed for transforming a plant, which enables the production of a plant-made classical swine fever virus antigen, specifically the pmE2 protein. This method offers a high-efficiency production process that is safer and more stable compared to traditional methods. The plant-derived antigen also features a cellulose-binding domain protein, which serves as an effective marker for tracking virus exposure and antibody production pathways.
Career Highlights
Throughout his career, Seong In Lim has worked with various organizations, including Bioapplications Inc. and the Republic of Korea's Animal and Plant Quarantine Agency. His work has focused on enhancing vaccine safety and efficacy through innovative biotechnological methods.
Collaborations
Seong In Lim has collaborated with notable colleagues such as Dong Jun An and Jae Young Song. These partnerships have contributed to the advancement of research in vaccine development and plant biotechnology.
Conclusion
Seong In Lim's contributions to vaccine development through innovative plant-based methods highlight the potential of biotechnology in addressing agricultural and veterinary challenges. His work continues to pave the way for safer and more effective vaccines.